- Shares of HUL slumped 5.17% today to touch their 52-week lows at ₹1983.55 apiece.
- It posted a 16.76% rise in standalone net profit to ₹2,243 crores in Q3FY22, i.e., the October to December quarter.
- In Feb 2022, HUL hiked the prices of its products by anywhere between 3% to 13% in multiple tranches in February 2022.
Shares of HUL slumped 5.17% today to touch their 52-week lows at ₹1983.55 apiece. The FMCG major’s shares are on the losing run for 9 consecutive trading sessions.
Its shares have declined 14.2% in these sessions from their previous high of ₹2,312 per share, posted on 18th February 2022. Its 52-week high is 2,859.30 per share and it is down by 30.6% from this number. Its market capitalization is 4.76 lakh crores.
The Nifty 50 has fallen by 6.44% in one month, while the share has fallen by 12.51% during the same period.
HUL Limited posted a 16.76% rise in standalone net profit to ₹2,243 crores in Q3FY22, i.e., the October to December quarter. During the same period last year, it had earned a profit of ₹1,921 crores.
In Feb 2022, HUL hiked the prices of its products by anywhere between 3% to 13% in multiple tranches February 2022. They had to do this due to a constant rise in raw material costs due to an increase in crude oil prices that impact transport, logistics as well as material costs.
As per a report dated January 20, 2022, Prabhudas Lilladher has given a ‘buy’ rating on the stock with a target price of ₹2,900.
As per a report dated January 20, 2022, ICICI Securities has given a buy call on Hindustan Unilever with a target price of ₹2,500. The time period given by the analyst is one year.
Hindustan Unilever’s key products/ revenue segments include personal care and other operating revenue. Promoters hold a 61.90% stake in the company, the public holds a 12.46% stake, FIIs hold 14.92% and DIIs hold 10.72%.
Disclaimer
The content in this news article is not investment advice. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
